R. Delarue

Discipline

Economies et finances (2) Sociologie (1) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (8)

Co-auteur

Date

Source

Mot-clé

Lymphomas (7) Treatment (3) Cases (3) Patients (3) Human beings (3) Addition (3) Cases (3) Patients (3) procès (2) survie (2) Diagnosis (2) Chemotherapy (2) Methods (2) T cells (2) Survival (2) RNA (2) Months (2) Expression (2) Diagnosis (2) Cycles (2) Chemotherapy (2) Methods (2) Rituximab (2) Practice (2) tissu (corporel) (1) thérapie (1) test (1) bassin de retenue (1) recherche (1) protéine (1)

Documents écrit par R. Delarue (8) | parle de R. Delarue (0)

Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
A. Abdel-Sater et al.
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
D. Vallois et al.
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
M.P. Dobay et al.
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.
L. de Leval et al. (2015)
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
C. Bossard et al. (6 nov. 2014)
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
N. Ketterer et al. (2013)
Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
M.H. Delfau-Larue et al. (2012)
Late recovery of renal failure after autologous haematopoietic stem cell transplantation for multiple myeloma: a report of two cases
N. Bige et al.